JP5174659B2 - リウマチ疾患の診断方法 - Google Patents

リウマチ疾患の診断方法 Download PDF

Info

Publication number
JP5174659B2
JP5174659B2 JP2008518703A JP2008518703A JP5174659B2 JP 5174659 B2 JP5174659 B2 JP 5174659B2 JP 2008518703 A JP2008518703 A JP 2008518703A JP 2008518703 A JP2008518703 A JP 2008518703A JP 5174659 B2 JP5174659 B2 JP 5174659B2
Authority
JP
Japan
Prior art keywords
polypeptide
vimentin
detection
rheumatoid arthritis
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008518703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008543961A5 (https=
JP2008543961A (ja
Inventor
バング ホルガー
ベルク ヴィクベルト
Original Assignee
オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical オルゲンテック ディアグノスティカ ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2008543961A publication Critical patent/JP2008543961A/ja
Publication of JP2008543961A5 publication Critical patent/JP2008543961A5/ja
Application granted granted Critical
Publication of JP5174659B2 publication Critical patent/JP5174659B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
JP2008518703A 2005-06-27 2006-06-27 リウマチ疾患の診断方法 Active JP5174659B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005029845.1 2005-06-27
DE102005029845.1A DE102005029845B4 (de) 2005-06-27 2005-06-27 Verfahren zur Diagnose von rheumatischen Erkrankungen
PCT/EP2006/006205 WO2007000320A2 (de) 2005-06-27 2006-06-27 Verfahren zur diagnose von rheumatischen erkrankungen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012193246A Division JP2013032358A (ja) 2005-06-27 2012-09-03 リウマチ疾患の診断方法

Publications (3)

Publication Number Publication Date
JP2008543961A JP2008543961A (ja) 2008-12-04
JP2008543961A5 JP2008543961A5 (https=) 2009-07-23
JP5174659B2 true JP5174659B2 (ja) 2013-04-03

Family

ID=37309237

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008518703A Active JP5174659B2 (ja) 2005-06-27 2006-06-27 リウマチ疾患の診断方法
JP2012193246A Pending JP2013032358A (ja) 2005-06-27 2012-09-03 リウマチ疾患の診断方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012193246A Pending JP2013032358A (ja) 2005-06-27 2012-09-03 リウマチ疾患の診断方法

Country Status (8)

Country Link
US (1) US8999921B2 (https=)
EP (1) EP1896497B1 (https=)
JP (2) JP5174659B2 (https=)
CN (1) CN101282989A (https=)
AU (1) AU2006263942B9 (https=)
CA (1) CA2614103C (https=)
DE (2) DE102005029845B4 (https=)
WO (1) WO2007000320A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029845B4 (de) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von rheumatischen Erkrankungen
CA2690568A1 (en) * 2007-06-20 2008-12-24 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
EP2204380A1 (en) 2008-12-23 2010-07-07 Charité-Universitätsmedizin Berlin hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis
NZ608489A (en) 2009-03-30 2014-08-29 Nestec Sa Citrullinated peptides for diagnosing and prognosing rheumatiod arthritis
CN102229652B (zh) * 2009-10-23 2012-05-23 山东省医药生物技术研究中心 抗类风湿性关节炎的多肽及其在制药中的应用
US10011883B2 (en) 2011-10-14 2018-07-03 New York University Causative agents and diagnostic methods relating to rheumatoid arthritis
WO2013151314A1 (ko) * 2012-04-03 2013-10-10 연세대학교 산학협력단 비멘틴을 포함하는 탈모 억제 또는 발모 촉진용 조성물
GB201214007D0 (en) 2012-08-07 2012-09-19 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
WO2016199964A1 (ko) * 2015-06-10 2016-12-15 주식회사 이뮨메드 분리된 비멘틴 유래 펩타이드에 특이적으로 결합하는 항체 또는 상기 펩타이드의 결합 단편
GB201512703D0 (en) 2015-07-20 2015-08-26 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
CN106950365B (zh) * 2017-02-15 2018-11-27 中国医学科学院北京协和医院 一种acpa阴性的ra诊断标志物及其应用
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
KR102511660B1 (ko) * 2020-11-18 2023-03-20 한양대학교 에리카산학협력단 비멘틴 돌연변이체 또는 이를 발현하는 벡터를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900473D0 (sv) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation
EP1207862A2 (en) * 1999-06-07 2002-05-29 The University Of Sheffield Arthritis treatment
CA2518187A1 (en) * 2003-03-07 2004-09-16 London Health Sciences Centre Reseach, Inc. Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases
DE102005029845B4 (de) 2005-06-27 2017-03-23 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von rheumatischen Erkrankungen

Also Published As

Publication number Publication date
EP1896497A2 (de) 2008-03-12
DE102005029845A1 (de) 2007-01-11
CA2614103C (en) 2015-02-24
DE202006020682U1 (de) 2009-07-23
AU2006263942B2 (en) 2012-03-29
US20090155822A1 (en) 2009-06-18
WO2007000320A2 (de) 2007-01-04
CA2614103A1 (en) 2007-01-04
CN101282989A (zh) 2008-10-08
JP2013032358A (ja) 2013-02-14
DE102005029845B4 (de) 2017-03-23
AU2006263942B9 (en) 2012-08-02
JP2008543961A (ja) 2008-12-04
WO2007000320A3 (de) 2007-07-05
EP1896497B1 (de) 2017-07-12
US8999921B2 (en) 2015-04-07
AU2006263942A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
JP2013032358A (ja) リウマチ疾患の診断方法
US6489118B2 (en) Allergenic proteins and peptides from dog dander and uses therefor
TR201815856T4 (tr) Bradikinin-aracılı rahatsızlıkların değerlendirilmesi ve tedavisi.
CA2757444A1 (en) Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
JP2016511394A (ja) ｐＫａｌ関連疾病の評価、アッセイおよび治療
Zhao et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity
KR100328112B1 (ko) 류마토이드관절염병원관련관절염성펩티드에대항하는면역보호유도에유용한백신조성물과방법
WO2001018550A9 (en) Determination of adrenomedullin-binding proteins
US8323656B2 (en) Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
JP4313433B2 (ja) イミュノグロブリン結合能を有するペプチド
KR20120007492A (ko) 이뮤노글로불린 결합능을 갖는 펩티드
JP5156997B2 (ja) Ｉｖ型コラーゲン様免疫活性ペプチド
US20170114112A1 (en) Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
CA2374000A1 (en) Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
JP2005504321A (ja) 慢性の炎症性腸疾患の診断と治療の為の方法と薬剤。
HK1124345A (en) Method for diagnosing rheumatic diseases
HK40037298A (en) Method for predicting clinical effect of immunotherapy
WO2017050976A1 (en) Ephb2 polypeptides and uses thereof for the diagnosis and treatment of lupus

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090604

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090604

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20101227

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20101228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120206

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120305

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120903

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120910

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20121002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121214

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121228

R150 Certificate of patent or registration of utility model

Ref document number: 5174659

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250